nodes	percent_of_prediction	percent_of_DWPC	metapath
Iopamidol—Neutropenia—Vincristine—colon cancer	0.003	0.003	CcSEcCtD
Iopamidol—Apnoea—Methotrexate—colon cancer	0.00293	0.00293	CcSEcCtD
Iopamidol—Neutropenia—Irinotecan—colon cancer	0.00293	0.00293	CcSEcCtD
Iopamidol—Angina pectoris—Fluorouracil—colon cancer	0.00292	0.00292	CcSEcCtD
Iopamidol—Extravasation—Methotrexate—colon cancer	0.00285	0.00285	CcSEcCtD
Iopamidol—Acute coronary syndrome—Vincristine—colon cancer	0.00282	0.00282	CcSEcCtD
Iopamidol—Neuropathy peripheral—Vincristine—colon cancer	0.00281	0.00281	CcSEcCtD
Iopamidol—Myocardial infarction—Vincristine—colon cancer	0.00281	0.00281	CcSEcCtD
Iopamidol—Thrombophlebitis—Capecitabine—colon cancer	0.0028	0.0028	CcSEcCtD
Iopamidol—Musculoskeletal stiffness—Methotrexate—colon cancer	0.00277	0.00277	CcSEcCtD
Iopamidol—Acute coronary syndrome—Irinotecan—colon cancer	0.00275	0.00275	CcSEcCtD
Iopamidol—Swelling—Capecitabine—colon cancer	0.00275	0.00275	CcSEcCtD
Iopamidol—Sweating—Vincristine—colon cancer	0.00275	0.00275	CcSEcCtD
Iopamidol—Renal failure—Irinotecan—colon cancer	0.00274	0.00274	CcSEcCtD
Iopamidol—Myocardial infarction—Irinotecan—colon cancer	0.00273	0.00273	CcSEcCtD
Iopamidol—Deafness—Capecitabine—colon cancer	0.00271	0.00271	CcSEcCtD
Iopamidol—Oliguria—Methotrexate—colon cancer	0.0027	0.0027	CcSEcCtD
Iopamidol—Sweating—Irinotecan—colon cancer	0.00267	0.00267	CcSEcCtD
Iopamidol—Acute coronary syndrome—Fluorouracil—colon cancer	0.00263	0.00263	CcSEcCtD
Iopamidol—Myocardial infarction—Fluorouracil—colon cancer	0.00262	0.00262	CcSEcCtD
Iopamidol—Neuropathy peripheral—Fluorouracil—colon cancer	0.00262	0.00262	CcSEcCtD
Iopamidol—Conjunctivitis—Fluorouracil—colon cancer	0.0026	0.0026	CcSEcCtD
Iopamidol—Hot flush—Capecitabine—colon cancer	0.00259	0.00259	CcSEcCtD
Iopamidol—Amnesia—Capecitabine—colon cancer	0.00258	0.00258	CcSEcCtD
Iopamidol—Menopausal symptoms—Capecitabine—colon cancer	0.00257	0.00257	CcSEcCtD
Iopamidol—Hypoaesthesia—Vincristine—colon cancer	0.00256	0.00256	CcSEcCtD
Iopamidol—Hallucination—Vincristine—colon cancer	0.00256	0.00256	CcSEcCtD
Iopamidol—Bradycardia—Irinotecan—colon cancer	0.00255	0.00255	CcSEcCtD
Iopamidol—Haemoglobin—Irinotecan—colon cancer	0.00252	0.00252	CcSEcCtD
Iopamidol—Rhinitis—Irinotecan—colon cancer	0.00251	0.00251	CcSEcCtD
Iopamidol—Haemorrhage—Irinotecan—colon cancer	0.0025	0.0025	CcSEcCtD
Iopamidol—Cardiac failure—Capecitabine—colon cancer	0.00248	0.00248	CcSEcCtD
Iopamidol—Pain in extremity—Capecitabine—colon cancer	0.00242	0.00242	CcSEcCtD
Iopamidol—Visual impairment—Irinotecan—colon cancer	0.00241	0.00241	CcSEcCtD
Iopamidol—Haemoglobin—Fluorouracil—colon cancer	0.00241	0.00241	CcSEcCtD
Iopamidol—Rhinitis—Fluorouracil—colon cancer	0.0024	0.0024	CcSEcCtD
Iopamidol—Depressed level of consciousness—Methotrexate—colon cancer	0.0024	0.0024	CcSEcCtD
Iopamidol—Haemorrhage—Fluorouracil—colon cancer	0.0024	0.0024	CcSEcCtD
Iopamidol—Hypoaesthesia—Fluorouracil—colon cancer	0.00239	0.00239	CcSEcCtD
Iopamidol—Skin exfoliation—Methotrexate—colon cancer	0.00237	0.00237	CcSEcCtD
Iopamidol—Face oedema—Capecitabine—colon cancer	0.00234	0.00234	CcSEcCtD
Iopamidol—Flushing—Irinotecan—colon cancer	0.00232	0.00232	CcSEcCtD
Iopamidol—Irritability—Capecitabine—colon cancer	0.00231	0.00231	CcSEcCtD
Iopamidol—Urinary retention—Capecitabine—colon cancer	0.0023	0.0023	CcSEcCtD
Iopamidol—Cardiac arrest—Capecitabine—colon cancer	0.0023	0.0023	CcSEcCtD
Iopamidol—Ataxia—Capecitabine—colon cancer	0.00228	0.00228	CcSEcCtD
Iopamidol—Coma—Methotrexate—colon cancer	0.00227	0.00227	CcSEcCtD
Iopamidol—Chills—Irinotecan—colon cancer	0.00225	0.00225	CcSEcCtD
Iopamidol—Arrhythmia—Irinotecan—colon cancer	0.00224	0.00224	CcSEcCtD
Iopamidol—Pulmonary oedema—Methotrexate—colon cancer	0.00221	0.00221	CcSEcCtD
Iopamidol—Back pain—Vincristine—colon cancer	0.00217	0.00217	CcSEcCtD
Iopamidol—Arrhythmia—Fluorouracil—colon cancer	0.00214	0.00214	CcSEcCtD
Iopamidol—Muscular weakness—Capecitabine—colon cancer	0.00214	0.00214	CcSEcCtD
Iopamidol—Back pain—Irinotecan—colon cancer	0.00211	0.00211	CcSEcCtD
Iopamidol—Muscle spasms—Irinotecan—colon cancer	0.0021	0.0021	CcSEcCtD
Iopamidol—Asthma—Capecitabine—colon cancer	0.00209	0.00209	CcSEcCtD
Iopamidol—Thrombophlebitis—Methotrexate—colon cancer	0.00208	0.00208	CcSEcCtD
Iopamidol—Bronchospasm—Capecitabine—colon cancer	0.00206	0.00206	CcSEcCtD
Iopamidol—Agitation—Vincristine—colon cancer	0.00206	0.00206	CcSEcCtD
Iopamidol—Angina pectoris—Capecitabine—colon cancer	0.00204	0.00204	CcSEcCtD
Iopamidol—Sweating increased—Capecitabine—colon cancer	0.00204	0.00204	CcSEcCtD
Iopamidol—Ill-defined disorder—Irinotecan—colon cancer	0.00202	0.00202	CcSEcCtD
Iopamidol—Malaise—Irinotecan—colon cancer	0.00197	0.00197	CcSEcCtD
Iopamidol—Neutropenia—Capecitabine—colon cancer	0.00196	0.00196	CcSEcCtD
Iopamidol—Syncope—Irinotecan—colon cancer	0.00195	0.00195	CcSEcCtD
Iopamidol—Convulsion—Vincristine—colon cancer	0.00194	0.00194	CcSEcCtD
Iopamidol—Hypertension—Vincristine—colon cancer	0.00193	0.00193	CcSEcCtD
Iopamidol—Loss of consciousness—Irinotecan—colon cancer	0.00192	0.00192	CcSEcCtD
Iopamidol—Myalgia—Vincristine—colon cancer	0.00191	0.00191	CcSEcCtD
Iopamidol—Visual disturbance—Methotrexate—colon cancer	0.0019	0.0019	CcSEcCtD
Iopamidol—Cough—Irinotecan—colon cancer	0.0019	0.0019	CcSEcCtD
Iopamidol—Hypertension—Irinotecan—colon cancer	0.00188	0.00188	CcSEcCtD
Iopamidol—Anaphylactoid reaction—Methotrexate—colon cancer	0.00186	0.00186	CcSEcCtD
Iopamidol—Acute coronary syndrome—Capecitabine—colon cancer	0.00184	0.00184	CcSEcCtD
Iopamidol—Renal failure—Capecitabine—colon cancer	0.00184	0.00184	CcSEcCtD
Iopamidol—Discomfort—Irinotecan—colon cancer	0.00183	0.00183	CcSEcCtD
Iopamidol—Neuropathy peripheral—Capecitabine—colon cancer	0.00183	0.00183	CcSEcCtD
Iopamidol—Myocardial infarction—Capecitabine—colon cancer	0.00183	0.00183	CcSEcCtD
Iopamidol—Anaphylactic shock—Vincristine—colon cancer	0.00183	0.00183	CcSEcCtD
Iopamidol—Infection—Vincristine—colon cancer	0.00181	0.00181	CcSEcCtD
Iopamidol—Conjunctivitis—Capecitabine—colon cancer	0.00181	0.00181	CcSEcCtD
Iopamidol—Convulsion—Fluorouracil—colon cancer	0.00181	0.00181	CcSEcCtD
Iopamidol—Confusional state—Irinotecan—colon cancer	0.00179	0.00179	CcSEcCtD
Iopamidol—Haematuria—Capecitabine—colon cancer	0.00178	0.00178	CcSEcCtD
Iopamidol—Anaphylactic shock—Irinotecan—colon cancer	0.00178	0.00178	CcSEcCtD
Iopamidol—Chest pain—Fluorouracil—colon cancer	0.00178	0.00178	CcSEcCtD
Iopamidol—Myalgia—Fluorouracil—colon cancer	0.00178	0.00178	CcSEcCtD
Iopamidol—Infection—Irinotecan—colon cancer	0.00177	0.00177	CcSEcCtD
Iopamidol—Hyperhidrosis—Vincristine—colon cancer	0.00177	0.00177	CcSEcCtD
Iopamidol—Discomfort—Fluorouracil—colon cancer	0.00176	0.00176	CcSEcCtD
Iopamidol—Shock—Irinotecan—colon cancer	0.00175	0.00175	CcSEcCtD
Iopamidol—Anorexia—Vincristine—colon cancer	0.00174	0.00174	CcSEcCtD
Iopamidol—Irritability—Methotrexate—colon cancer	0.00172	0.00172	CcSEcCtD
Iopamidol—Hyperhidrosis—Irinotecan—colon cancer	0.00172	0.00172	CcSEcCtD
Iopamidol—Confusional state—Fluorouracil—colon cancer	0.00172	0.00172	CcSEcCtD
Iopamidol—Hypotension—Vincristine—colon cancer	0.00171	0.00171	CcSEcCtD
Iopamidol—Bradycardia—Capecitabine—colon cancer	0.00171	0.00171	CcSEcCtD
Iopamidol—Anaphylactic shock—Fluorouracil—colon cancer	0.0017	0.0017	CcSEcCtD
Iopamidol—Anorexia—Irinotecan—colon cancer	0.0017	0.0017	CcSEcCtD
Iopamidol—Ataxia—Methotrexate—colon cancer	0.0017	0.0017	CcSEcCtD
Iopamidol—Infection—Fluorouracil—colon cancer	0.00169	0.00169	CcSEcCtD
Iopamidol—Haemoglobin—Capecitabine—colon cancer	0.00168	0.00168	CcSEcCtD
Iopamidol—Rhinitis—Capecitabine—colon cancer	0.00168	0.00168	CcSEcCtD
Iopamidol—Haemorrhage—Capecitabine—colon cancer	0.00168	0.00168	CcSEcCtD
Iopamidol—Hypoaesthesia—Capecitabine—colon cancer	0.00167	0.00167	CcSEcCtD
Iopamidol—Musculoskeletal discomfort—Vincristine—colon cancer	0.00166	0.00166	CcSEcCtD
Iopamidol—Tachycardia—Fluorouracil—colon cancer	0.00166	0.00166	CcSEcCtD
Iopamidol—Hypotension—Irinotecan—colon cancer	0.00166	0.00166	CcSEcCtD
Iopamidol—Paraesthesia—Vincristine—colon cancer	0.00164	0.00164	CcSEcCtD
Iopamidol—Anorexia—Fluorouracil—colon cancer	0.00162	0.00162	CcSEcCtD
Iopamidol—Visual impairment—Capecitabine—colon cancer	0.00162	0.00162	CcSEcCtD
Iopamidol—Paraesthesia—Irinotecan—colon cancer	0.0016	0.0016	CcSEcCtD
Iopamidol—Hypotension—Fluorouracil—colon cancer	0.00159	0.00159	CcSEcCtD
Iopamidol—Decreased appetite—Vincristine—colon cancer	0.00159	0.00159	CcSEcCtD
Iopamidol—Dyspnoea—Irinotecan—colon cancer	0.00159	0.00159	CcSEcCtD
Iopamidol—Fatigue—Vincristine—colon cancer	0.00157	0.00157	CcSEcCtD
Iopamidol—Dyspepsia—Irinotecan—colon cancer	0.00157	0.00157	CcSEcCtD
Iopamidol—Tinnitus—Capecitabine—colon cancer	0.00156	0.00156	CcSEcCtD
Iopamidol—Pain—Vincristine—colon cancer	0.00156	0.00156	CcSEcCtD
Iopamidol—Asthma—Methotrexate—colon cancer	0.00156	0.00156	CcSEcCtD
Iopamidol—Flushing—Capecitabine—colon cancer	0.00156	0.00156	CcSEcCtD
Iopamidol—Musculoskeletal discomfort—Fluorouracil—colon cancer	0.00155	0.00155	CcSEcCtD
Iopamidol—Decreased appetite—Irinotecan—colon cancer	0.00155	0.00155	CcSEcCtD
Iopamidol—Fatigue—Irinotecan—colon cancer	0.00153	0.00153	CcSEcCtD
Iopamidol—Paraesthesia—Fluorouracil—colon cancer	0.00153	0.00153	CcSEcCtD
Iopamidol—Pain—Irinotecan—colon cancer	0.00152	0.00152	CcSEcCtD
Iopamidol—Dyspnoea—Fluorouracil—colon cancer	0.00152	0.00152	CcSEcCtD
Iopamidol—Chills—Capecitabine—colon cancer	0.0015	0.0015	CcSEcCtD
Iopamidol—Dyspepsia—Fluorouracil—colon cancer	0.0015	0.0015	CcSEcCtD
Iopamidol—Arrhythmia—Capecitabine—colon cancer	0.0015	0.0015	CcSEcCtD
Iopamidol—Decreased appetite—Fluorouracil—colon cancer	0.00148	0.00148	CcSEcCtD
Iopamidol—Feeling abnormal—Irinotecan—colon cancer	0.00147	0.00147	CcSEcCtD
Iopamidol—Neutropenia—Methotrexate—colon cancer	0.00146	0.00146	CcSEcCtD
Iopamidol—Pain—Fluorouracil—colon cancer	0.00146	0.00146	CcSEcCtD
Iopamidol—Abdominal pain—Vincristine—colon cancer	0.00144	0.00144	CcSEcCtD
Iopamidol—Body temperature increased—Vincristine—colon cancer	0.00144	0.00144	CcSEcCtD
Iopamidol—Dysgeusia—Capecitabine—colon cancer	0.00143	0.00143	CcSEcCtD
Iopamidol—Back pain—Capecitabine—colon cancer	0.00141	0.00141	CcSEcCtD
Iopamidol—Body temperature increased—Irinotecan—colon cancer	0.00141	0.00141	CcSEcCtD
Iopamidol—Abdominal pain—Irinotecan—colon cancer	0.00141	0.00141	CcSEcCtD
Iopamidol—Feeling abnormal—Fluorouracil—colon cancer	0.0014	0.0014	CcSEcCtD
Iopamidol—Muscle spasms—Capecitabine—colon cancer	0.0014	0.0014	CcSEcCtD
Iopamidol—Tremor—Capecitabine—colon cancer	0.00137	0.00137	CcSEcCtD
Iopamidol—Renal failure—Methotrexate—colon cancer	0.00137	0.00137	CcSEcCtD
Iopamidol—Ill-defined disorder—Capecitabine—colon cancer	0.00135	0.00135	CcSEcCtD
Iopamidol—Urticaria—Fluorouracil—colon cancer	0.00135	0.00135	CcSEcCtD
Iopamidol—Conjunctivitis—Methotrexate—colon cancer	0.00135	0.00135	CcSEcCtD
Iopamidol—Body temperature increased—Fluorouracil—colon cancer	0.00135	0.00135	CcSEcCtD
Iopamidol—Sweating—Methotrexate—colon cancer	0.00133	0.00133	CcSEcCtD
Iopamidol—Haematuria—Methotrexate—colon cancer	0.00133	0.00133	CcSEcCtD
Iopamidol—Malaise—Capecitabine—colon cancer	0.00132	0.00132	CcSEcCtD
Iopamidol—Asthenia—Vincristine—colon cancer	0.00131	0.00131	CcSEcCtD
Iopamidol—Syncope—Capecitabine—colon cancer	0.00131	0.00131	CcSEcCtD
Iopamidol—Loss of consciousness—Capecitabine—colon cancer	0.00128	0.00128	CcSEcCtD
Iopamidol—Asthenia—Irinotecan—colon cancer	0.00128	0.00128	CcSEcCtD
Iopamidol—Cough—Capecitabine—colon cancer	0.00127	0.00127	CcSEcCtD
Iopamidol—Hypertension—Capecitabine—colon cancer	0.00126	0.00126	CcSEcCtD
Iopamidol—Haemoglobin—Methotrexate—colon cancer	0.00125	0.00125	CcSEcCtD
Iopamidol—Diarrhoea—Vincristine—colon cancer	0.00125	0.00125	CcSEcCtD
Iopamidol—Haemorrhage—Methotrexate—colon cancer	0.00125	0.00125	CcSEcCtD
Iopamidol—Chest pain—Capecitabine—colon cancer	0.00124	0.00124	CcSEcCtD
Iopamidol—Myalgia—Capecitabine—colon cancer	0.00124	0.00124	CcSEcCtD
Iopamidol—Anxiety—Capecitabine—colon cancer	0.00124	0.00124	CcSEcCtD
Iopamidol—Discomfort—Capecitabine—colon cancer	0.00123	0.00123	CcSEcCtD
Iopamidol—Diarrhoea—Irinotecan—colon cancer	0.00122	0.00122	CcSEcCtD
Iopamidol—Dizziness—Vincristine—colon cancer	0.00121	0.00121	CcSEcCtD
Iopamidol—Pruritus—Fluorouracil—colon cancer	0.00121	0.00121	CcSEcCtD
Iopamidol—Visual impairment—Methotrexate—colon cancer	0.0012	0.0012	CcSEcCtD
Iopamidol—Confusional state—Capecitabine—colon cancer	0.0012	0.0012	CcSEcCtD
Iopamidol—Infection—Capecitabine—colon cancer	0.00118	0.00118	CcSEcCtD
Iopamidol—Dizziness—Irinotecan—colon cancer	0.00118	0.00118	CcSEcCtD
Iopamidol—Shock—Capecitabine—colon cancer	0.00117	0.00117	CcSEcCtD
Iopamidol—Diarrhoea—Fluorouracil—colon cancer	0.00117	0.00117	CcSEcCtD
Iopamidol—Tinnitus—Methotrexate—colon cancer	0.00116	0.00116	CcSEcCtD
Iopamidol—Tachycardia—Capecitabine—colon cancer	0.00116	0.00116	CcSEcCtD
Iopamidol—Vomiting—Vincristine—colon cancer	0.00116	0.00116	CcSEcCtD
Iopamidol—Rash—Vincristine—colon cancer	0.00115	0.00115	CcSEcCtD
Iopamidol—Hyperhidrosis—Capecitabine—colon cancer	0.00115	0.00115	CcSEcCtD
Iopamidol—Dermatitis—Vincristine—colon cancer	0.00115	0.00115	CcSEcCtD
Iopamidol—Headache—Vincristine—colon cancer	0.00114	0.00114	CcSEcCtD
Iopamidol—Anorexia—Capecitabine—colon cancer	0.00113	0.00113	CcSEcCtD
Iopamidol—Vomiting—Irinotecan—colon cancer	0.00113	0.00113	CcSEcCtD
Iopamidol—Dizziness—Fluorouracil—colon cancer	0.00113	0.00113	CcSEcCtD
Iopamidol—Rash—Irinotecan—colon cancer	0.00112	0.00112	CcSEcCtD
Iopamidol—Dermatitis—Irinotecan—colon cancer	0.00112	0.00112	CcSEcCtD
Iopamidol—Chills—Methotrexate—colon cancer	0.00112	0.00112	CcSEcCtD
Iopamidol—Headache—Irinotecan—colon cancer	0.00111	0.00111	CcSEcCtD
Iopamidol—Hypotension—Capecitabine—colon cancer	0.00111	0.00111	CcSEcCtD
Iopamidol—Nausea—Vincristine—colon cancer	0.00109	0.00109	CcSEcCtD
Iopamidol—Musculoskeletal discomfort—Capecitabine—colon cancer	0.00108	0.00108	CcSEcCtD
Iopamidol—Vomiting—Fluorouracil—colon cancer	0.00108	0.00108	CcSEcCtD
Iopamidol—Rash—Fluorouracil—colon cancer	0.00107	0.00107	CcSEcCtD
Iopamidol—Dermatitis—Fluorouracil—colon cancer	0.00107	0.00107	CcSEcCtD
Iopamidol—Paraesthesia—Capecitabine—colon cancer	0.00107	0.00107	CcSEcCtD
Iopamidol—Headache—Fluorouracil—colon cancer	0.00107	0.00107	CcSEcCtD
Iopamidol—Dysgeusia—Methotrexate—colon cancer	0.00106	0.00106	CcSEcCtD
Iopamidol—Dyspnoea—Capecitabine—colon cancer	0.00106	0.00106	CcSEcCtD
Iopamidol—Nausea—Irinotecan—colon cancer	0.00106	0.00106	CcSEcCtD
Iopamidol—Back pain—Methotrexate—colon cancer	0.00105	0.00105	CcSEcCtD
Iopamidol—Dyspepsia—Capecitabine—colon cancer	0.00105	0.00105	CcSEcCtD
Iopamidol—Decreased appetite—Capecitabine—colon cancer	0.00104	0.00104	CcSEcCtD
Iopamidol—Fatigue—Capecitabine—colon cancer	0.00103	0.00103	CcSEcCtD
Iopamidol—Pain—Capecitabine—colon cancer	0.00102	0.00102	CcSEcCtD
Iopamidol—Nausea—Fluorouracil—colon cancer	0.00101	0.00101	CcSEcCtD
Iopamidol—Ill-defined disorder—Methotrexate—colon cancer	0.00101	0.00101	CcSEcCtD
Iopamidol—Feeling abnormal—Capecitabine—colon cancer	0.000981	0.000981	CcSEcCtD
Iopamidol—Malaise—Methotrexate—colon cancer	0.000979	0.000979	CcSEcCtD
Iopamidol—Cough—Methotrexate—colon cancer	0.000948	0.000948	CcSEcCtD
Iopamidol—Urticaria—Capecitabine—colon cancer	0.000946	0.000946	CcSEcCtD
Iopamidol—Abdominal pain—Capecitabine—colon cancer	0.000941	0.000941	CcSEcCtD
Iopamidol—Body temperature increased—Capecitabine—colon cancer	0.000941	0.000941	CcSEcCtD
Iopamidol—Convulsion—Methotrexate—colon cancer	0.000941	0.000941	CcSEcCtD
Iopamidol—Myalgia—Methotrexate—colon cancer	0.000925	0.000925	CcSEcCtD
Iopamidol—Chest pain—Methotrexate—colon cancer	0.000925	0.000925	CcSEcCtD
Iopamidol—Discomfort—Methotrexate—colon cancer	0.000914	0.000914	CcSEcCtD
Iopamidol—Confusional state—Methotrexate—colon cancer	0.000894	0.000894	CcSEcCtD
Iopamidol—Anaphylactic shock—Methotrexate—colon cancer	0.000886	0.000886	CcSEcCtD
Iopamidol—Infection—Methotrexate—colon cancer	0.000881	0.000881	CcSEcCtD
Iopamidol—Hyperhidrosis—Methotrexate—colon cancer	0.000857	0.000857	CcSEcCtD
Iopamidol—Asthenia—Capecitabine—colon cancer	0.000854	0.000854	CcSEcCtD
Iopamidol—Anorexia—Methotrexate—colon cancer	0.000845	0.000845	CcSEcCtD
Iopamidol—Pruritus—Capecitabine—colon cancer	0.000842	0.000842	CcSEcCtD
Iopamidol—Hypotension—Methotrexate—colon cancer	0.000828	0.000828	CcSEcCtD
Iopamidol—Diarrhoea—Capecitabine—colon cancer	0.000815	0.000815	CcSEcCtD
Iopamidol—Musculoskeletal discomfort—Methotrexate—colon cancer	0.000808	0.000808	CcSEcCtD
Iopamidol—Paraesthesia—Methotrexate—colon cancer	0.000796	0.000796	CcSEcCtD
Iopamidol—Dyspnoea—Methotrexate—colon cancer	0.00079	0.00079	CcSEcCtD
Iopamidol—Dizziness—Capecitabine—colon cancer	0.000787	0.000787	CcSEcCtD
Iopamidol—Dyspepsia—Methotrexate—colon cancer	0.00078	0.00078	CcSEcCtD
Iopamidol—Decreased appetite—Methotrexate—colon cancer	0.000771	0.000771	CcSEcCtD
Iopamidol—Fatigue—Methotrexate—colon cancer	0.000764	0.000764	CcSEcCtD
Iopamidol—Pain—Methotrexate—colon cancer	0.000758	0.000758	CcSEcCtD
Iopamidol—Vomiting—Capecitabine—colon cancer	0.000757	0.000757	CcSEcCtD
Iopamidol—Rash—Capecitabine—colon cancer	0.000751	0.000751	CcSEcCtD
Iopamidol—Dermatitis—Capecitabine—colon cancer	0.00075	0.00075	CcSEcCtD
Iopamidol—Headache—Capecitabine—colon cancer	0.000746	0.000746	CcSEcCtD
Iopamidol—Feeling abnormal—Methotrexate—colon cancer	0.00073	0.00073	CcSEcCtD
Iopamidol—Nausea—Capecitabine—colon cancer	0.000707	0.000707	CcSEcCtD
Iopamidol—Urticaria—Methotrexate—colon cancer	0.000704	0.000704	CcSEcCtD
Iopamidol—Body temperature increased—Methotrexate—colon cancer	0.000701	0.000701	CcSEcCtD
Iopamidol—Abdominal pain—Methotrexate—colon cancer	0.000701	0.000701	CcSEcCtD
Iopamidol—Asthenia—Methotrexate—colon cancer	0.000636	0.000636	CcSEcCtD
Iopamidol—Pruritus—Methotrexate—colon cancer	0.000627	0.000627	CcSEcCtD
Iopamidol—Diarrhoea—Methotrexate—colon cancer	0.000606	0.000606	CcSEcCtD
Iopamidol—Dizziness—Methotrexate—colon cancer	0.000586	0.000586	CcSEcCtD
Iopamidol—Vomiting—Methotrexate—colon cancer	0.000564	0.000564	CcSEcCtD
Iopamidol—Rash—Methotrexate—colon cancer	0.000559	0.000559	CcSEcCtD
Iopamidol—Dermatitis—Methotrexate—colon cancer	0.000558	0.000558	CcSEcCtD
Iopamidol—Headache—Methotrexate—colon cancer	0.000555	0.000555	CcSEcCtD
Iopamidol—Nausea—Methotrexate—colon cancer	0.000526	0.000526	CcSEcCtD
